AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $41.2 million versus the consensus estimate of $42.03 million.

GUIDANCE:

AtriCure sees FY2017 EPS of $0.94-$1.04. Sees revenues up 13-15%.

For earnings history and earnings-related data on AtriCure (ATRC) click here.